Skip to main content
Premium Trial:

Request an Annual Quote

Leica, Abbott Developing Automated FISH Test for HER2

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Leica Microsystems and Abbott today announced a deal to develop a fully automated fluorescent in situ hybridization solution for HER2 testing.

Under the terms of the deal, Abbott will supply FISH probes targeting the HER2 gene locus, which will be used to develop the automated HER2 FISH test on Leica's BOND automated advanced staining platform.

Terms of the deal were not disclosed.

In a statement, Leica said that Abbott's PathVysion FISH assay is the gold standard ISH test for diagnosing response to Herceptin, a frontline therapy for breast cancer. Leica will develop an automated version of the test on the BOND platform using a standard protocol, and said that automation on its platform "will enable pathology laboratories to run this diagnostic test more efficiently."

Abbott's PathVysion HER-2 DNA Probe Kit is FDA approved and is designed to detect amplification of the HER-2/neu gene via FISH in formalin-fixed, paraffin-embedded human breast cancer tissue specimens.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.